Fennec Pharmaceuticals Inc. Common Stock
Symbol: FENC (NASDAQ)
8.78
▲ (0.69%) 0.060
Company Description:
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Key Stats
- Today's Open: $8.57
- Today's High: $8.78
- Today's Low: $8.4
- Today's Volume: 61.22K
- Yesterday Close: $8.72
- Yesterday High: $8.84
- Yesterday Low: $8.39
- Yesterday Volume: 79.01K
- Last Min Volume: 0
- Last Min High: $8.78
- Last Min Low: $8.78
- Last Min VWAP: $0
Company Profile
- Name: Fennec Pharmaceuticals Inc. Common Stock
- Website: https://www.fennecpharma.com
- Listed Date: 2002-01-28
- Location: RESEARCH TRIANGLE PARK, NC
- Market Status: Active
- CIK Number: 0001211583
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $242.69M
- Round Lot: 100
- Outstanding Shares: 27.83M
- Asset Type: CS
RECENT FILINGS FOR FENC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-14 | 4 | View |
| 2025-10-10 | 144 | View |
| 2025-10-09 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-06 | 4 | View |
| 2025-10-06 | 144 | View |
| 2025-10-01 | 4 | View |
| 2025-10-01 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-04 | 144 | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 4 | View |
| 2025-09-02 | 4 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 144 | View |
| 2025-08-01 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |
Latest News on FENC